240 related articles for article (PubMed ID: 19398346)
1. Biological evaluation of boronated unnatural amino acids as new boron carriers.
Kabalka GW; Yao ML; Marepally SR; Chandra S
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S374-9. PubMed ID: 19398346
[TBL] [Abstract][Full Text] [Related]
2. Quantitative evaluation of boron neutron capture therapy (BNCT) drugs for boron delivery and retention at subcellular-scale resolution in human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).
Chandra S; Ahmad T; Barth RF; Kabalka GW
J Microsc; 2014 Jun; 254(3):146-56. PubMed ID: 24684609
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of unnatural cyclic amino acids as boron delivery agents for treatment of melanomas and gliomas.
Barth RF; Kabalka GW; Yang W; Huo T; Nakkula RJ; Shaikh AL; Haider SA; Chandra S
Appl Radiat Isot; 2014 Jun; 88():38-42. PubMed ID: 24393770
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution and subcellular localization of an unnatural boron-containing amino acid (cis-ABCPC) by imaging secondary ion mass spectrometry for neutron capture therapy of melanomas and gliomas.
Chandra S; Barth RF; Haider SA; Yang W; Huo T; Shaikh AL; Kabalka GW
PLoS One; 2013; 8(9):e75377. PubMed ID: 24058680
[TBL] [Abstract][Full Text] [Related]
5. Boronated unnatural cyclic amino acids as potential delivery agents for neutron capture therapy.
Kabalka GW; Shaikh AL; Barth RF; Huo T; Yang W; Gordnier PM; Chandra S
Appl Radiat Isot; 2011 Dec; 69(12):1778-81. PubMed ID: 21481596
[TBL] [Abstract][Full Text] [Related]
6. Quantitative subcellular imaging of boron compounds in individual mitotic and interphase human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).
Chandra S; Tjarks W; Lorey DR; Barth RF
J Microsc; 2008 Jan; 229(Pt 1):92-103. PubMed ID: 18173648
[TBL] [Abstract][Full Text] [Related]
7. Selectivity of boron carriers for boron neutron capture therapy: pharmacological studies with borocaptate sodium, L-boronophenylalanine and boric acid in murine tumors.
Gregoire V; Begg AC; Huiskamp R; Verrijk R; Bartelink H
Radiother Oncol; 1993 Apr; 27(1):46-54. PubMed ID: 8327732
[TBL] [Abstract][Full Text] [Related]
8. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
[TBL] [Abstract][Full Text] [Related]
9. Accelerator-based boron neutron capture therapy for malignant glioma: a pilot neutron irradiation study using boron phenylalanine, sodium borocaptate and liposomal borocaptate with a heterotopic U87 glioblastoma model in SCID mice.
Zavjalov E; Zaboronok A; Kanygin V; Kasatova A; Kichigin A; Mukhamadiyarov R; Razumov I; Sycheva T; Mathis BJ; Maezono SEB; Matsumura A; Taskaev S
Int J Radiat Biol; 2020 Jul; 96(7):868-878. PubMed ID: 32339057
[No Abstract] [Full Text] [Related]
10. Quantitative subcellular secondary ion mass spectrometry (SIMS) imaging of boron-10 and boron-11 isotopes in the same cell delivered by two combined BNCT drugs: in vitro studies on human glioblastoma T98G cells.
Chandra S; Lorey II DR; Smith DR
Radiat Res; 2002 Jun; 157(6):700-10. PubMed ID: 12005550
[TBL] [Abstract][Full Text] [Related]
11. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
Barth RF; Yang W; Rotaru JH; Moeschberger ML; Boesel CP; Soloway AH; Joel DD; Nawrocky MM; Ono K; Goodman JH
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):209-18. PubMed ID: 10758326
[TBL] [Abstract][Full Text] [Related]
12. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.
Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA
Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448
[TBL] [Abstract][Full Text] [Related]
13. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
[TBL] [Abstract][Full Text] [Related]
14. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.
Chadha M; Capala J; Coderre JA; Elowitz EH; Iwai J; Joel DD; Liu HB; Wielopolski L; Chanana AD
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):829-34. PubMed ID: 9531367
[TBL] [Abstract][Full Text] [Related]
15. Long-term infusions of p-boronophenylalanine for boron neutron capture therapy: evaluation using rat brain tumor and spinal cord models.
Morris GM; Micca PL; Nawrocky MM; Weissfloch LE; Coderre JA
Radiat Res; 2002 Dec; 158(6):743-52. PubMed ID: 12452777
[TBL] [Abstract][Full Text] [Related]
16. Dynamic secondary ion mass spectrometry analysis of boron from boron neutron capture therapy drugs in co-cultures: single-cell imaging of two different cell types within the same ion microscopy field of imaging.
Lorey DR; Morrison GH; Chandra S
Anal Chem; 2001 Aug; 73(16):3947-53. PubMed ID: 11534721
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of carborane-containing porphyrins as tumour targeting agents for boron neutron capture therapy.
Miura M; Micca PL; Fisher CD; Gordon CR; Heinrichs JC; Slatkin DN
Br J Radiol; 1998 Jul; 71(847):773-81. PubMed ID: 9771389
[TBL] [Abstract][Full Text] [Related]
18. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
[TBL] [Abstract][Full Text] [Related]
19. Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents.
Yang W; Barth RF; Wu G; Tjarks W; Binns P; Riley K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S328-31. PubMed ID: 19467880
[TBL] [Abstract][Full Text] [Related]
20. Application of a novel boronated porphyrin (H₂OCP) as a dual sensitizer for both PDT and BNCT.
Hiramatsu R; Kawabata S; Miyatake S; Kuroiwa T; Easson MW; Vicente MG
Lasers Surg Med; 2011 Jan; 43(1):52-8. PubMed ID: 21254143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
